ROIV
Roivant Sciences Ltd. · Healthcare
Director Vivek Ramaswamy sold $31.8M of Roivant Sciences Ltd.
Sold$31,800,000
$7.95Price
4,000,000Shares
−7%Stake
What ROIV did after the filing
- The stock from Thu, Feb 23 open, $8.20
- −10.0%
- S&P 500, same days
- +2.3%
Measured over 30 trading days, to the Apr 6 close.
Traded Wed, Feb 22. Filed Wed, Feb 22, 5:04 PM ET, after the close. Returns use the Feb 23 open and the Apr 6 close. Not investment advice.